Declining sales during the second quarter at Boston Scientific pushed its share price lower in trading this morning, as a company official said trends will force the medical device company to reduce its expenses and “headcount.”
Declining sales during the second quarter at Boston Scientific pushed its share price lower in trading this morning, as a company official said trends will force the medical device company to reduce its expenses and “headcount.”